00000nam 2200000zi 4500 9.885926 CaOODSP 20221107171302 m o d f cr ||||||||||| 200417t20202020oncd ob f000 0 eng d 9780660345949 (part 1) 9780660345956 (part 2) CaOODSP eng rda CaOODSP n-cn--- H82-50/1-2020E-PDF H82-50/2-2020E-PDF Biologics in Canada. Ottawa, ON : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, 2020. ©2020 1 online resource (2 volumes) : graphs text txt rdacontent computer c rdamedia online resource cr rdacarrier "May 2020." Cover title. Issued also in HTML format. "Chartbook National Prescription Drug Utilization Information System (NPDUIS)"--Cover. Issued also in French under title: Les médicaments biologiques au Canada. Includes bibliographical references (page 31). Part 1: Market trends, 2018 -- Part 2: Biosimilar savings, 2018. "This analysis examines the market dynamics of biologics in Canada and compares Canadian and international trends in sales, pricing, and biosimilar uptake. Part 2 uses recent Canadian and international trends to expose the current and future cost savings that could be realized through increasing the uptake and/or lowering the prices of biosimilars in Canada"--Introduction, page 5. Biologicals Canada. Biologicals Prices Canada. Pharmaceutical industry Canada. Canada. Patented Medicine Prices Review Board, issuing body. Les médicaments biologiques au Canada. (CaOODSP)9.885927 PDF 1.23 MB https://publications.gc.ca/collections/collection_2020/cepmb-pmprb/H82-50-1-2020-eng.pdf Part 1 PDF 1.06 MB https://publications.gc.ca/collections/collection_2020/cepmb-pmprb/H82-50-2-2020-eng.pdf Part 2 HTML N/A https://www.canada.ca/en/patented-medicine-prices-review/services/reports-studies/biologics-part1-market-trends.html Part 1 HTML N/A https://www.canada.ca/en/patented-medicine-prices-review/services/reports-studies/biologics-part2-biosimilar-savings2018.html Part 2